Pharmaceutical Analysis & Statistics, January 2015 (p50)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

1471-1500 of about 21 000 reports

Purchase Reports From Reputable Market Research Publishers

Uzbekistan Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Uzbekistan Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Uzbekistan is Central Asia’s largest industry by population, although its pharmaceutical industry lags that of neighbouring Kazakhstan in value terms, with per capita spending on pharmaceuticals ...

  • Industries : Drug and Medication
  • Countries : Uzbekistan
Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Sri Lanka’s pharmaceutical industry is expected to post a from 2010 to 2015 compound annual growth rate (CAGR) of 10.2%, as measured in local currency terms. Nevertheless, by 2015, the industry ...

  • Industries : Pharmaceutical
  • Countries : Sri Lanka
Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI calculates that pharmaceutical revenues in Venezuela, under pressure from economic and pricing factors, reached VEB12.76bn (US Dollar 5.95bn) in 2009, a 31.2% local currency year-on-year (y-o-y) increase. ...

  • Industries : Drug and Medication
  • Countries : Venezuela
Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: It is beyond doubt that drugmakers in Greece – particularly domestic producers primarily exposed to their home industry – are faced with the most challenging operating environment in Europe. ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Despite a downgrade in our economic outlook for Serbia, BMI's expenditure projections for the pharmaceutical industry for from 2012 to 2015 are up moderately due to revisions to our previous ...

  • Industries : Generic Drug
  • Countries : Serbia and Montenegro
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Moldova’s small industry size and its status as the poorest countries in Europe limit its attractiveness as a destination for investment. However, it is the most liberal country in the Commonwealth ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Ghana’s pharmaceutical industry is expected to post double-digit year-on-year (y-o-y) growth again in 2011, which will partly be due to inflation. Per capita spending on medicines will remain ...

  • Industries : Drug and Medication
  • Countries : Ghana
United Arab Emirates Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

United Arab Emirates Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: In 2010, the UAE pharmaceutical industry reached a value of AED5.71bn (US Dollar 1.56bn). One of the key drivers of growth for the UAE pharmaceutical industry is increased health expenditure. ...

  • Industries : Drug and Medication
  • Countries : United Arab Emirates
Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Puerto Rico has long held a reputation as a hotspot for foreign pharmaceutical investment, due to its low cost base and affiliation as a US territory with commonwealth status, offering investors ...

  • Industries : Drug and Medication
  • Countries : United States
Brazil Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Brazil Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Brazil’s large population, combined with strong private consumption, bodes well for foreign drugmakers looking to capitalise on the growth trajectory of Latin America’s largest healthcare ...

  • Industries : Drug and Medication
  • Countries : Brazil
Israel Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Israel Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Our opinion that industrial action in Israel would result in a rise in public healthcare expenditure has played out. The government is promising an additional ILS2.7bn (US Dollar 764mn) a yea ...

  • Industries : Drug and Medication
  • Countries : Israel
Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: The potential of the Slovakian pharmaceutical industry in the short term has been subdued by recent legislative changes. The government's most significant and damaging measure is the introduction ...

  • Industries : Prescription Drug
  • Countries : Slovakia (slovak Republic)
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: South Africa's timescale for enacting its National Health Insurance (NHI) scheme is practical and achievable, as are the country’s plans to improve governance, administration and funding. However, ...

  • Industries : Drug and Medication
  • Countries : South Africa
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

The Czech Republic retains its pole position in BMI’s Q111 Regional Business Environment Ratings (BERs) for Emerging Europe. In our global table, the Czech Republic moved upward, placing 12th, now being ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Egypt Pharmaceuticals and Healthcare Report Q1 2015

Egypt Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Recent developments have led us to hold a more positive outlook for Egypt's pharmaceutical and healthcare markets. An increased healthcare budget for 2015, combined with the government's efforts ...

  • Industries : Drug and Medication
  • Countries : Egypt
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Demographic considerations – in combination with concerted cost-containment pressures that form part of fiscal austerity measures – will continue to hamper the development of the Lithuanian ...

  • Industries : Drug and Medication
  • Countries : Lithuania
Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • January 2015
  • by Business Monitor International

BMI View: Despite our generally positive outlook for much of Latin America in 2012, we maintain the view that mounting fiscal pressures and a faltering business environment will damage Mexico’s attractiveness ...

  • Industries : Generic Drug
  • Countries : Mexico
Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Indonesia will continue to represent a high-risk but high-reward pharmaceutical industry for multinationals, on account of its deficient regulatory and intellectual property (IP) environment ...

  • Industries : Drug and Medication
  • Countries : Indonesia
United States Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Healthcare spending in the US will continue to account for a disproportionately large percentage of its Gross Domestic Product . Citizens of the world's largest economy are accustomed to regula ...

  • Industries : Pharmaceutical
  • Countries : United States
Morocco Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: According to the figures provided by l’Association Marocaine de l’Industrie Pharmaceutique (AMIP), drug expenditure in Morocco reached a value of MAD9.00bn (US Dollar 1.14bn) in 2010. We ...

  • Industries : Drug and Medication
  • Countries : Morocco
Oman Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Oman Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: While Oman is viewed favourably in terms of operating risks, constraints on medicine pricing and the small population will continue to drag down its rewards score. Nevertheless, oil revenues ...

  • Industries : Pharmaceutical
  • Countries : Oman
Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Spain Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: We believe the Spanish government's austerity measures are a necessary and prudent course of action. The country still has the third highest budget deficit in the eurozone and continues to receive ...

  • Industries : Drug and Medication
  • Countries : Spain
Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Renewed liberalisation of Russia’s pharmaceutical industry could follow the final approval of the country’s membership of the World Trade Organisation (WTO) at the end of 2011. Liberalisation ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belgium Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The expected growth of Belgium’s ageing population will have an unprecedented effect on the provision of healthcare. The elderly require more medical check-ups and care than young people due ...

  • Industries : Drug and Medication
  • Countries : Belgium
Colombia Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Colombia’s newly elected government, led by President Juan Manuel Santos, will continue to re-establish diplomatic relations, resulting in the realignment of foreign policy focus from the US towards ...

  • Industries : Drug and Medication
  • Countries : Colombia
Peru Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Peru Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Despite its steady growth over the past decade, Peru remains a relatively small pharmaceutical industry – valued at no more than US Dollar 1.1bn in 2010 – despite the population size nudging ...

  • Industries : Drug and Medication
  • Countries : Peru
Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: Malaysia's growing domestic pharmaceutical industry continues to attract drugmakers into the country. Increased private spending power and government investment in healthcare infrastructure should ...

  • Industries : Drug and Medication
  • Countries : Malaysia
Ireland Pharmaceuticals and Healthcare Report Q1 2015

Ireland Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The US Treasury Department's modification of tax rules in order to discourage tax inversions will continue to curb the number of M&A deals in the pharmaceutical industry that allow companies ...

  • Industries : Prescription Drug
  • Countries : Ireland
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

BMI View: The Belarusian pharmaceutical industry has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuticals. ...

  • Industries : Drug and Medication
  • Countries : Belarus
Finland Pharmaceuticals and Healthcare Report Q1 2015

Finland Pharmaceuticals and Healthcare Report Q1 2015

  • $ 1 300
  • Industry report
  • December 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Finland, like many other Western countries, has a mature pharmaceutical market where growth is slowing. Although an ageing population will drive the demand ...

  • Industries : Drug and Medication
  • Countries : Finland
About 50 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • March 2015
    3 pages
  • Influenza  

View report >

Drug Production

February 2015

About 500 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

Pfizer Inc.

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.